Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse model
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Repeated scanning ultrasound in the absence of a therapeutic agent removes amyloid-β and restores memory in an Alzheimer’s disease mouse model.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our results support previous studies showing improved behaviour in AD mouse models associated with enhanced microglial amyloid plaque phagocytosis in response to scanning ultrasound69, and treatment with IL-33 that signals exclusively via MyD8870.”
From Transcriptional signature in microglia associated with Aβ plaque phagocytosis (2021) · cites this paper as [69]
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedSoluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · cited 1×
“An entire series of sections was processed for Campbell-Switzer silver staining (36) using a protocol available online at http://neuroscienceassociates.”
MethodScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078 · cited 1×
“Ab is elevated in the AD brain because of the increased production of this peptide and its impaired removal (4, 5).”
BackgroundDendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821 · cited 1×
“At the age of 12 to 13 months, APP23 mice have a substantial plaque burden and spatial memory deficits (17).”
BackgroundSelf-citationTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Amyloid-β and tau--a toxic pas de deux in Alzheimer’s disease
Ittner, L. M., & Götz, J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2967 · Cited by 1,269
Self-citationAlzheimer’s disease: Clinical trials and drug development
Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217 · cited 1×
“Recent therapeutic strategies have targeted both processes (6), including the inhibition of secretase enzymes to reduce Ab production, as well as active and, in particular, passive immunization approaches for boosting Ab clearance.”
The secretases: enzymes with therapeutic potential in Alzheimer disease
De Strooper, B., Vassar, R., & Golde, T. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.218 · Cited by 799 · cited 1×
“Inhibition of secretases affects additional substrates with potential off-target effects (7), and passive immunization may be costly once effectiveness is demonstrated in clinical trials (8).”
Background
Cited by
Items 301–400 of 514
D'Arrigo, J. S. (2017) · Medical Sciences · doi:10.3390/medsci5040029 · Cited by 21
“It is believed that (non-thermal focused) ultrasound pulses cause the (intravenously injected) preformed microbubbles to expand and contract (with acoustic pressure rarefaction and compression, respectively) against the BBB structure, thereby loosening the tight junctions [1,2] between endothelial cells which form the…”
BackgroundMethodInfluentialTang, Y., Qian, X., Lee, D. J., Zhou, Q., & Yao, J. (2020) · OBM Neurobiology · doi:10.21926/obm.neurobiol.2002056 · Cited by 17
“used a focused US strategy to remove plaque without the need for a therapeutic agent such as an anti-Aβ antibody (Figure 9) (67).”
MethodInnovative Applications of MR-Guided Focused Ultrasound for Neurological Disorders
Stavarache, M. A., Chazen, J. L., & Kaplitt, M. G. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.08.052 · Cited by 14
Wen, J., Deng, X., Huang, C., An, Z., & Liu, M. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00020 · Cited by 15
Targeting Early Dementia: Using Lipid Cubic Phase Nanocarriers to Cross the Blood–Brain Barrier
D'Arrigo, J. S. (2018) · Biomimetics · doi:10.3390/biomimetics3010004 · Cited by 17
“, “loosening the tight junctions of the cells forming the BBB” via 327 ultrasound irradiation [158,159]), might carry an additional effect.”
Noninvasive Neuromodulation in Parkinson’s Disease: Insights from Animal Models
Muksuris, K., Scarisbrick, D. M., Mahoney, J. J., & Cherkasova, M. V. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175448 · Cited by 14
Clinical neurophysiology in the treatment of movement disorders: IFCN handbook chapter
Lefaucheur, J., Moro, E., Shirota, Y., Ugawa, Y., Grippe, T. C., Chen, R. E., Benninger, D. H., Jabbari, B., Attaripour, S., Hallett, M., et al. (2024) · Clinical Neurophysiology · doi:10.1016/j.clinph.2024.05.007 · Cited by 17
Precise modulation of cell activity using sono-responsive nano-transducers
Hou, X., Liu, L., & Sun, L. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122857 · Cited by 15
Samra, G. K., Dang, K., Ho, H., Baranwal, A., & Mukherjee, J. (2018) · Medicinal Chemistry Research · doi:10.1007/s00044-018-2178-9 · Cited by 14
“repeatedly used on the mouse brain to make the blood–brain barrier (BBB) leaky for Aβ removal (#6 Table 1; Leinenga and Gotz 2015).”
MethodTranslating Alzheimer’s Disease Mechanisms into Therapeutic Opportunities
Li, J., Wang, L., Zhang, X., Shi, J., Zhu, Y. Z., Wang, H., Zhu, X., Zhu, Q., & Luo, J. (2025) · Biomolecules · doi:10.3390/biom15091290 · Cited by 16
“The amount of plaque was lower in SUS-treated mice with AD compared to those that did not receive treatment; even more importantly, their ability to remember where things were, learn new locations, and recall information in the short term improved [122].”
Ultrasound Molecular Imaging and Drug Delivery
Caskey, C. F. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1058-x · Cited by 13
Modulation of tau protein aggregation using ‘Trojan’ sequences
Pandey, G., Morla, S., Kumar, S., & Ramakrishnan, V. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129569 · Cited by 13
Micro/nanoparticle-enabled ultrasound therapy of brain diseases
Qiu, L., Zhu, Z., Liang, J., Qiao, X., Xu, H., Xiang, H., Ding, H., & Chen, Y. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215531 · Cited by 12
Shen, Y. Y., Jethe, J. V., Reid, A. P., Hehir, J., Amaral, M. M., Ren, C., Hao, S., Zhou, C., & Fisher, J. A. N. (2025) · Communications Biology · doi:10.1038/s42003-024-07356-2 · Cited by 16
Azadian, M. M., Shabestari, S. K., Rajan, A., Martinez, P. J., Macedo, N., Markarian, E., Xiang, Y., Yu, B. J., George, P. M., Fame, R. M., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02866-8 · Cited by 18
“Low-intensity FUS paired with microbubbles may disrupt the blood– brain barrier, which clears Alzheimer’s-associated plaques in preclinical models 13 but also has sterile neuroinflammatory effects 14 and raises safety concerns, given the risk of microbubble inertial cavitation as well as practical…”
Best Medicine for Dementia: The Life-Long Defense of the Brain
Andersson, M. J., & Stone, J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230429 · Cited by 14
Anticoagulants inhibit proteolytic clearance of plasma amyloid beta
Yang, L., Bhattacharya, A., Li, Y., & Zhang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.23718 · Cited by 12
Modeling ultrasound propagation through material of increasing geometrical complexity
Odabaee, M., Odabaee, M., Pelekanos, M., Leinenga, G., & Götz, J. (2018) · Ultrasonics · doi:10.1016/j.ultras.2018.05.014 · Cited by 12
Self-citationDielectrophoresis of Amyloid-Beta Proteins as a Microfluidic Template for Alzheimer’s Research
Al-Ahdal, S. A., Kayani, A. B. A., Ali, M. A. M., Chan, J. Y., Ali, T., Adnan, N., Buyong, M. R., Noor, E. E. M., Majlis, B. Y., & Sriram, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143595 · Cited by 12
“Parameters for the Clausius – Mossoti Factor Calculation. protein size, r Aβ 5 to 15 (nm) [7,37] protein conductivity, Aβ Simulation was conducted to ascertain the fields generated by the DEP microelectrodes. distributions E were simulated using Agros2D 3.2, Czech Republic.”
BackgroundMethodInfluentialKoberskaya, N. N. (2019) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2019-3s-52-60 · Cited by 12
Kline-Schoder, A. R., Noel, R. L., Phatnani, H. P., Menon, V., & Konofagou, E. E. (2023) · Neuroglia · doi:10.3390/neuroglia4020010 · Cited by 13
“Due to being entirely noninvasive and safe, focused ultrasound (FUS) has emerged as a promising method of neuroimmunotherapy for the treatment of a number of neurological disorders [3,4,6,9].”
MethodExosome-based regenerative rehabilitation: A novel ice breaker for neurological disorders
Wang, Y., Cheng, J., Liu, Y., Wang, Y.-P., Yang, Q., & Zhou, N. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115920 · Cited by 13
Miceli, M., Muscat, S., Morbiducci, U., Cavaglià, M., & Deriu, M. A. (2019) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2019.107518 · Cited by 12
Sexton, C. E., Anstey, K. J., Baldacci, F., Barnum, C. J., Barron, A. M., Blennow, K., Brodaty, H., Burnham, S. C., Elahi, F. M., Götz, J., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12380 · Cited by 13
Self-citationUltrasound‐assisted ocular drug delivery: A review of current evidence
Yang, C. D., Jessen, J., & Lin, K. Y. (2022) · Journal of Clinical Ultrasound · doi:10.1002/jcu.23214 · Cited by 12
“Another study demonstrates that scanning ultrasound can remove beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease.(68) These results suggest that ultrasound treatment may be a safe and efficacious nonpharmalogical therapeutic tool for”
BackgroundAlzheimer’s Disease: An Overview
Dunne, T. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397045-9.00139-7 · Cited by 11
Ultrasound and antibodies — a potentially powerful combination for Alzheimer disease therapy
Götz, J., & Padmanabhan, P. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00943-1 · Cited by 12
“In mice, Aβ has been shown to be cleared by microglial phagocytosis in response to ultrasound-mediated BBB opening even without antibody administration 6 .”
Self-citationThe Biopolitics of Dementia: A Neurocritical Perspective
Fletcher, J. R. (2023) · Routledge eBooks · doi:10.4324/9781003398523 · Cited by 15
Imaging strategies to assess efficacy and safety of ultrasound-induced blood-brain barrier opening
Pagé, G., Novell, A., & Larrat, B. (2025) · npj Acoustics · doi:10.1038/s44384-025-00024-7 · Cited by 11
Li, F., Wu, L., Feng, X., Li, Y., & Fan, H. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18010070 · Cited by 11
“For instance, scanning ultrasound alone has been shown to remove A β and restore cognitive function in AD mouse model [243].”
Wang, Q., Liu, T., Chang, H., Li, Z., Chen, L., Mi, X., Xing, H.-Y., Wang, X., Hong, J., Liu, K., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13040657 · Cited by 11
Chaves, J. C. S., Wasielewska, J. M., Cuní‐López, C., Rantanen, L. M., Lee, S., Koıstınaho, J., White, A. R., & Oikari, L. E. (2023) · Neurotherapeutics · doi:10.1016/j.neurot.2023.10.009 · Cited by 11
“MBs were prepared in-house as previously described [44,52] and further optimised by our group to use in vitro patient-derived model [42].”
MethodPremature or pathological aging: longevity
Sgarbieri, V. C., & Pacheco, M. T. B. (2017) · Brazilian journal of food technology/Brazilian Journal of Food Technology · doi:10.1590/1981-6723.19416 · Cited by 10
Ultrasound-Mediated Bioeffects in Senescent Mice and Alzheimer’s Mouse Models
Balbi, M., Blackmore, D. G., Padmanabhan, P., & Götz, J. (2022) · Brain Sciences · doi:10.3390/brainsci12060775 · Cited by 10
Self-citationZhang, C., Tan, R., Zhou, X., Wang, R., Wang, X., Ma, R., Chu, F., Li, Y., Yin, T., & Liu, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094651 · Cited by 11
The Application of Ultrasound‐Induced Blood–Brain Barrier Opening in Neurology and Immunology
Jiang, A., Wang, Z., Song, D., Zhang, X., Guan, M., Li, X., Tan, J., He, Y., Han, W., Ding, X., et al. (2025) · Small · doi:10.1002/smll.202502699 · Cited by 12
Focused transcranial ultrasound stimulation: a breakthrough approach to treating brain disorders
Vanneste, S., Reynolds, J. N. J., & Ridder, D. D. (2025) · Expert Review of Medical Devices · doi:10.1080/17434440.2025.2563618 · Cited by 10
Le, H. T. N., Giang, V. T. T., Abioye, A. O., & Adejare, A. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18020192 · Cited by 10
“Preclinical AD models in rodents and non-human primates have demonstrated the effectiveness of FUS in reducing AD pathology, even in the absence of therapeutic intervention [61,62].”
Wang, N., Zhang, C., Wei, X., Yan, T., Zhou, W., Zhang, J., Kang, H., Yuan, Z., & Chen, X. (2023) · Biomedical Optics Express · doi:10.1364/boe.501893 · Cited by 9
Zhou, M., Fu, X., Ma, B., Chen, Z., Cheng, Y., Liu, L., Kan, S., Zhao, X., Feng, S., Jiang, Z., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1274642 · Cited by 9
What Future for Ultrasound in Medicine?
Tovoli, F., Cantisani, V., Schiavone, C., & Piscaglia, F. (2018) · Ultraschall in der Medizin - European Journal of Ultrasound · doi:10.1055/s-0043-125421 · Cited by 9
“…to transiently open the blood-brain barrier in localized brain regions also offers a promising route for targeted drug delivery, potentially leading to novel therapeutic approaches in chemotherapy delivery for brain cancers [5] and in albu-min-mediated plaque clearance in Alzheimer ’ s disease [6].”
Shaw, C. A. (2017) · Wiley eBooks · doi:10.1002/9781118634523.refs · Cited by 9
Focused ultrasound‐mediated APOE4 knockdown in mouse brain
Zheng, K., Tsitsos, F. N., Batts, A. J., Ji, R., Nuriel, T., Konofagou, E. E., & Leong, K. W. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70464 · Cited by 8
Fuh, J., Wang, S.-J., Wang, P., Wu, H., Su, W.-S., Lin, H.-M., & Yang, F. (2025) · Ultrasonics · doi:10.1016/j.ultras.2025.107844 · Cited by 11
Batts, A. J., Tsitsos, F. N., Ingabire, J., Duret, G., Gorman, S. L., Tsakri, D., Noel, R. L., Ji, R., Kwon, N., Pham, Q.-K., et al. (2025) · Brain stimulation · doi:10.1016/j.brs.2025.10.006 · Cited by 9
Focused Ultrasound for Neurodegenerative Diseases
Mehta, R. I., Ranjan, M., Haut, M. W., Carpenter, J., & Rezai, A. R. (2024) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2024.03.001 · Cited by 8
Cai, Q., Meng, L., Quan, M., Wang, L., Ren, J., Zheng, C., Yang, J., & Ming, D. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00539 · Cited by 9
Bensalem, J., Hein, L. K., Hassiotis, S., Trim, P. J., Proud, C. G., Heilbronn, L. K., & Sargeant, T. J. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.02.035 · Cited by 9
Focused ultrasound therapy: Back to the future
Metman, L. V., Monje, M. H. G., Obeso, J. A., & Martínez‐Fernández, R. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.106023 · Cited by 9
A mechanism for ultrasound/light-induced biostimulation.
Sommer, A. P. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.09.18 · Cited by 8
“Therefore, the recently reported substantial reduction of Aβ42 plaques in the brain of mice by the synergistic interplay of transcranially applied ultrasound waves and biologically inert micron sized microbubbles has a strong momentum of surprise (3).”
BackgroundIncreasing BBB Permeability via Focused Ultrasound: Current Methods in Preclinical Research
McMahon, D., Poon, C., & Hynynen, K. (2018) · Neuromethods · doi:10.1007/978-1-4939-8946-1_16 · Cited by 8
Liu, L., Du, J., Zheng, T., Hu, S., Zhao, M., Wang, X., Wu, S., Wu, S., & Shi, Q. (2019) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2019.06.013 · Cited by 8
Saha, D., & Jana, B. (2021) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp01866c · Cited by 8
Human Ultrasound Neuromodulation: State of the Art
Beisteiner, R. (2022) · Brain Sciences · doi:10.3390/brainsci12020208 · Cited by 8
“Important insights for the development of human and medical applications also came from animal studies [5].”
BackgroundGrubman, A., Choo, X. Y., Chew, G., Ouyang, J. F., Sun, G., Croft, N. P., Rossello, F. J., Simmons, R., Buckberry, S., Landin, D. V., et al. (2019) · doi:10.1101/639054 · Cited by 7
Bai, M., Lyv, H., Zhou, X., Zhang, Y., & Han, Z. (2025) · Journal of Alzheimer's Disease Reports · doi:10.1177/25424823251343789 · Cited by 7
“10,11 However, its regulatory effects on human cerebral A β pathology require further investigation.”
InfluentialSimão, S., Santos, D. F., Teixeira, M., Agostinho, R. R., Rodrigues, J., Vitorino, M., & Araújo, I. M. (2025) · Redox Report · doi:10.1080/13510002.2025.2592413 · Cited by 9
“In this regard, some examples include the use of a low-intensity focused ultrasound (LIFUS) apparatus, which activated neurogenesis in Sprague Dawley rats [33] and removed amyloid beta deposits and restored memory in a mouse model of AD [34].”
Chen, L., Song, J. H., Richter-Stretton, G. L., Lee, W., Padmanabhan, P., & Götz, J. (2024) · Nanotheranostics · doi:10.7150/ntno.95146 · Cited by 7
“10 Hz PRF and 6 s sonication per spot were chosen given that these parameters achieve good BBB opening in mice [19, 36, 50].”
Self-citationUltrasound-irradiated bindable microbomb opens the blood-brain barrier to enhance glioma therapy
Li, B., Zhong, H., Wei, H., Chen, G., Lin, M., Huang, S., Zhang, Q., Xing, C., Li, T., Huang, J., et al. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102312 · Cited by 7
Semyachkina-Glushkovskaya, O. V., Khorovodov, A. P., Fedosov, I. V., Павлов, А. Н., Shirokov, A. A., Shareef, A. E., Dubrovsky, A. I., Blokhina, I., Terskov, A. V., Наволокин, Н. А., et al. (2021) · Applied Sciences · doi:10.3390/app112110287 · Cited by 7
Research and progress of focused ultrasound in the treatment of Alzheimer’s disease
Ma, X., Li, T., Du, L., & Han, T. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1323386 · Cited by 8
“Leinenga et al. (30) found in the experiment of opening BBB of 10 APP23 transgenic mice that compared with 10 mice treated with sham, the number and surface area of A β plaques in mice treated with MRgFUS were reduced, and the mice performed better in three memory tasks: Y-maze, novel object…”
BackgroundMethodInfluentialBiological effects of rapid short pulses of focused ultrasound for drug delivery to the brain
Morse, S. V., Rimer, S., Geoghegan, G., Shah, M. D., Chan, N., Yalcin, C., Pereira, M. A., Rohfleisch, L., Nkontchou, N., Winiarski, S., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113646 · Cited by 8
Forced acoustic oscillations of biological cell
Kharlanov, A. V. (2017) · Bioelectromagnetics · doi:10.1002/bem.22078 · Cited by 7
“At present, sound is widely used for medical purposes, such as bone and soft tissue regeneration [Heckman et al., 1994; Speed, 2001; Padilla et al., 2014], treatment therapy for neurological disorders [Tufail et al., 2011; Leinenga and G€otz, 2015], etc. [Mitragotri, 2005; Deymier et al., 2015].”
MethodStable Cavitation Interferes with Aβ16–22 Oligomerization
Man, V. H., He, X., & Wang, J. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00764 · Cited by 7
Davidson, B., Schmidt, F. A., Bichsel, O., Hajiabadi, M. M., & Lozano, A. M. (2025) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2025.3624970 · Cited by 7
Yong, W., He, D., Chen, T., Rui, Z., Wen, Y., Wong, K. F., Sun, L., Qi, X., & Guo, J. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.07.034 · Cited by 7
In Vitro Treatment of Alzheimer’s Disease by Disintegrating Amyloid- β Using Electromagnetic Waves
Bhattacharjee, S., Choi, J., Park, S., Shim, K.-H., Baek, C., Han, H.-B., Hong, H.-C., Yun, S., Cha, M., Shah, Y. H., et al. (2025) · IEEE Transactions on Antennas and Propagation · doi:10.1109/tap.2025.3568638 · Cited by 5
“One such technique is scanning ultrasound, which aims to reduce amyloid plaques and potentially enhance drug delivery by temporarily opening the blood-brain barrier [10].”
Alzheimer’s disease: Toward the rational design of an effective vaccine.
Marciani, D. J. (2015) · Revista de Neuro-Psiquiatría · doi:10.20453/rnp.2015.2572 · Cited by 7
A Urinary Metabolomics Analysis Based on UPLC-MS and Effects of Moxibustion in APP/PS1 Mice
He, R., Liu, J., Huang, C., Liu, J., Cui, H., & Zhao, B. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666201109091759 · Cited by 6
Exploiting Focused Ultrasound to Aid Intranasal Drug Delivery for Brain Therapy
Barbato, G., Nisticò, R., & Triaca, V. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.786475 · Cited by 6
Loughran, S., Hossain, M. S. A., Bentvelzen, A., Elwood, M., Finnie, J. W., Horvat, J., Iskra, S., Ivanova, E. P., Manavis, J., Mudiyanselage, C., et al. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13100967 · Cited by 7
“Similar results have also been found after scanning ultrasound exposure of the brains of the same strain of transgenic mice [38].”
ResultAdvanced Microbubbles as a Multifunctional Platform Combining Imaging and Therapy
Ni, X., Ye, J., Wang, L., Xu, S., Zou, C., Yang, Y., & Liu, Z. (2016) · Applied Sciences · doi:10.3390/app6110365 · Cited by 6
“Leinenga applied repeated scanning ultrasound (SUS) for treatments of the mouse brain to remove Ab which is implicated in the pathogenesis of Alzheimer’s disease [76].”
MethodZalucki, O. H., Harkins, D., Harris, L., Burne, T. H. J., Gronostajski, R. M., & Piper, M. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3652-7 · Cited by 6
Xhima, K., McMahon, D., Ntiri, E. E., Goubran, M., Hynynen, K., & Aubert, I. (2021) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4056 · Cited by 7
Effects of blood-brain barrier opening using ultrasound on tauopathies: A systematic review
Géraudie, A., Rossi, P. D., Canney, M. S., Carpentier, A. C., & Delatour, B. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.056 · Cited by 8
Su, W.-S., Wu, M.-T., Cheng, I. H.-J., & Yang, F. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115420 · Cited by 5
Sharma, S., Fernandes, N. A. T. C., & Carvalho, Ó. S. N. (2025) · Bioengineering · doi:10.3390/bioengineering12111161 · Cited by 5
“LIFU has shown therapeutic potential in animal and human studies for conditions such as disorders of consciousness [26], epilepsy [27], Parkinson’s disease [28], Alzheimer’s disease [29], depression [30], dementia, and other mental or psychiatric disorders [31,32].”
Focused Ultrasound for Brain Diseases: A Review of Current Applications and Future Perspectives
Gionso, M., Raspagliesi, L., Yuan, L., Bene, M. D., Corradino, N., Ciocca, R., Porto, E., D’Ammando, A., Durando, G., Meco, F. D., et al. (2023) · IRBM · doi:10.1016/j.irbm.2023.100790 · Cited by 6
Emerging Novel Therapeutic Approaches for the Treatment of Alzheimer’s Disease
Panwar, A., Khan, M. I. K., Kumar, R., Kumar, R., Kumar, S., & Kumar, A. (2024) · Advances in Alzheimer s Disease · doi:10.4236/aad.2024.133006 · Cited by 5
Branca, J. J. V., Boninsegna, M., Morucci, G., Carrino, D., Nicoletti, C., Paternostro, F., Gulisano, M., Bocchi, L., & Pacini, A. (2023) · Cells · doi:10.3390/cells12010192 · Cited by 5
Delivery of Antibodies into the Brain Using Focused Scanning Ultrasound
Leinenga, G., Bodea, L., Koh, W. K., Nisbet, R. M., & Götz, J. (2020) · Journal of Visualized Experiments · doi:10.3791/61372 · Cited by 5
Self-citationSeo, S., Chang, W. S., Jeon, J.-G., Choi, Y., Kim, E. H., & Kim, J.-K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210739 · Cited by 5
“Changes in the oxidation state of magnetite occur upon dissociation from A (cid:2) after PS, resulting in the potential uptake of unbound magnetite and degraded amyloid protein by brain microglia as an anti-inflammatory response [41–43].”
[Mutation detection of COL1A1 gene in a pedigree with osteogenesis imperfecta].
Qin, W. D., He, J.-X., Shi, J. P., Xing, Q., Gao, J.-J., He, L., Qian, X., Liu, Z.-J., Shu, A., & He, L. (2005) · PubMed · Cited by 6
Valay, L., & Potier, M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70814 · Cited by 5
Lu, X., Sun, W., Leng, L., Yang, Y., Gong, S., Zou, Q., Niu, H., & Wei, C. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.70061 · Cited by 4
Low-intensity pulsed ultrasound elevates blood pressure for shock
Wu, C., Tian, Y. S., Liu, T., An, S., Yu, Q., Gao, C., Yuan, J., Liu, M., Nie, M., Jiang, W., et al. (2025) · Science Advances · doi:10.1126/sciadv.ads6947 · Cited by 4
“Furthermore, in the scope of Alzheimer’s disease, promising advancements have been uncovered with LIPUS; preclinical trials revealed that repeated ultrasound sessions fostered clearance of β - amyloid plaques, consequently enhancing cognitive functions ( 19 ).”
Low-intensity transcranial ultrasound stimulation and its regulatory effect on pain
Liu, Y., Tian, X., Chen, L., Xiao, C., Huang, X., & Wang, J. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.04.033 · Cited by 5
Improving Cognition Without Clearing Amyloid: Effects of Tau and Ultrasound Neuromodulation
Leinenga, G., Padmanabhan, P., & Götz, J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240616 · Cited by 4
“65 , 72 That SUS + MB achieved massive amyloid reductions was demonstrated in several ways: by Campbell-Switzer stains to separately visualize compact, mature plaques and diffuse aggregates, by western blotting of different fractions, and by ELISAs, all showing SUS + MB -mediated significant…”
Self-citationThe future of Alzheimer’s disease risk prediction: a systematic review
Nazir, S. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08167-x · Cited by 6
“Imaging methods such as MRI can identify these changes by displaying changes in blood flow, tissue micro-structure, and synaptic protein expression [38, 39].”
Deymier, P. A., Swinteck, N. Z., Runge, K., Deymier-Black, A. C., & Hoying, J. B. (2015) · Physical Review E · doi:10.1103/physreve.92.052711 · Cited by 4
Guillot‐Sestier, M., Weitz, T. M., & Town, T. (2016) · Journal of Visualized Experiments · doi:10.3791/54868 · Cited by 4
Коваленко, Е. А., Makhnovich, E. V., Osinovskaya, N. A., & Bogolepova, A. N. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212210138 · Cited by 4
Asymmetric Amyloid Deposition in the Brain Following Unilateral Electroconvulsive Therapy
Vandenbulcke, M., Bouckaert, F., Winter, F. D., Koole, M. J. B., Adamczuk, K., Vandenberghe, R. R., Emsell, L., & Laere, K. V. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.09.016 · Cited by 4
Villanueva, F. S., & Chen, X. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2019.08.010 · Cited by 4
Nestor, P. J., Pelekanos, M., Leinenga, G., Song, J., Lee, W., Richter-Stretton, G., McElligott, C., Fazlollahi, A., Mattingley, J. B., Harris, A., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf445 · Cited by 3
“6 Other groups similarly achieved amyloid-β clearance and functional improvements using this strategy.”
Self-citationLee, J. L., Song, J. H., Amor, R., Bolton, J., Thompson, A. W., Götz, J., & Padmanabhan, P. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113974 · Cited by 3
Self-citationNoel, R. L., Kline-Schoder, A. R., Batts, A. J., Kwon, N., Tsitsos, F., & Konofagou, E. E. (2025) · iScience · doi:10.1016/j.isci.2025.113173 · Cited by 3
Gladwell, R. A., Fisher, D. G., Wythe, J. D., Highley, C. B., Lukens, J. R., & Price, R. J. (2025) · Advanced Science · doi:10.1002/advs.202510684 · Cited by 3
Song, J. H., Richter-Stretton, G. L., Pelekanos, M., Clawson, C., Saifzadeh, S., Simon, C., Leinenga, G., Heras, R. D. L., Alexander, H., & Götz, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-25122-0 · Cited by 3
Self-citationLee, S., & Chang, J. W. (2026) · Journal of Clinical Neurology · doi:10.3988/jcn.2025.0563 · Cited by 5
“142 FUS-induced BBB opening also provokes an immune response in the brain—transiently upregulating genes like TREM2 and APOE that are involved in microglial activation and lipid metabolism, recruiting peripheral macrophages and T-cells to amyloid-laden regions, and modulating neuroinflammation from…”
Metadata
- Authors
- Leinenga, G., & Götz, J.
- Affiliations
- The University of Queensland (AU)
- Corresponding author
- Götz, Jürgen
- Venue
- Science Translational Medicine
- Published
- 2015-03-11
- Volume
- 7
- Issue
- 278
- Pages
- 278ra33-278ra33
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2169076271
- Cited by
- 498
- References
- 40
- Citations by year
- 2026: 24 · 2025: 39 · 2024: 40 · 2023: 50 · 2022: 41 · 2021: 52 · 2020: 51 · 2019: 40 · 2018: 44 · 2017: 55 · 2016: 36 · 2015: 25
- FWCI
- 39.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Australian Research Council (DP130101932)
- National Health and Medical Research Council of Australia (APP1037746, APP1003150)
- ARC Linkage Infrastructure, Equipment, and Facilities (LE130100078)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Physical Sciences › Engineering › Biomedical Engineering › Ultrasound and Hyperthermia Applications
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, non-pharmacological treatment, amyloid plaque clearance, microglia, memory recovery, mouse model
- MeSH terms
- Albumins, Alzheimer Disease, Animals, Blood-Brain Barrier, Cell Count, Disease Models, Animal, Humans, Inflammation, Lysosomes, Memory, Mice, Inbred C57BL, Mice, Transgenic, Phagocytosis, Ultrasonography, Ultrasonics, Amyloid beta-Peptides, Microglia, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.